Background: Macrosomia is a risk factor for adverse delivery outcomes. We investigated the prevalence, risk factors, and delivery outcomes of babies with macrosomia in 23 developing countries in Africa, Asia, and Latin America.
Methods: We analysed data from WHO's Global Survey on Maternal and Perinatal Health, which was a facility-based cross-sectional study that obtained data for women giving birth in 373 health facilities in 24 countries in Africa and Latin America in 2004-05, and in Asia in 2007-08. Facilities were selected by stratified multistage cluster sampling and women were recruited at admission for delivery. We extracted data from the medical records with a standardised questionnaire. We used logistic regression with random effects to assess the risk factors for macrosomia and the risks for caesarean section and adverse maternal and perinatal outcomes (assessed by a composite score) in babies with the disorder.
Findings: Of 290,610 deliveries, we analysed data for 276,436 singleton livebirths or fresh stillbirths. Higher maternal age (20-34 years), height, parity, body-mass index, and presence of diabetes, post-term pregnancy, and male fetal sex were associated with a significantly increased risk of macrosomia. Macrosomia was associated with an increased risk of caesarean section because of obstructed labour and post-term pregnancy in all regions. Additionally, macrosomia was associated with an increased risk of adverse maternal birth outcomes in all regions, and of adverse perinatal outcomes only in Africa.
Interpretation: Increasing prevalence of diabetes and obesity in women of reproductive age in developing countries could be associated with a parallel increase in macrosomic births. The effect and feasibility of control of diabetes and preconception weight on macrosomia should be investigated in these settings. Furthermore, increased institutional delivery in countries where rates are low could be crucial to reduce macrosomia-associated morbidity and mortality.
Funding: None.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0140-6736(12)61605-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Human Brucellosis in the Rural and Urban Population of Pakistan: Seroprevalence, Risk Factors, and Clinical Manifestations.
Curr Microbiol
January 2025
Razi Vaccine and Serum Research Institute (RVSRI), Agricultural Research, Education and Organization (AREEO), Karaj, Iran.
Brucella spp. is the bacterium responsible for brucellosis, a zoonotic infection that affects humans. This disease poses significant health challenges and contributes to poverty, particularly in developing countries.
View Article and Find Full Text PDFApproach Towards the Development of Digital Twin for Structural Health Monitoring of Civil Infrastructure: A Comprehensive Review.
Sensors (Basel)
December 2024
School of Engineering, RMIT University, 124 La Trobe Street, Melbourne, VIC 3000, Australia.
Civil infrastructure assets' contribution to countries' economic growth is significantly increasing due to the rapid population growth and demands for public services. These civil infrastructures, including roads, bridges, railways, tunnels, dams, residential complexes, and commercial buildings, experience significant deterioration from the surrounding harsh environment. Traditional methods of visual inspection and non-destructive tests are generally undertaken to monitor and evaluate the structural health of the infrastructure.
View Article and Find Full Text PDFKey Interleukins in Inflammatory Bowel Disease-A Review of Recent Studies.
Int J Mol Sci
December 2024
Department of Internal Medicine, Angiology and Physical Medicine, Center for Laser Diagnostics and Therapy, Medical University of Silesia in Katowice, Batorego 15 Street, 41-902 Bytom, Poland.
Inflammatory bowel disease (IBD) is an immune disorder of the gastrointestinal tract with a complex aetiopathogenesis, whose development is influenced by many factors. The prevalence of IBD is increasing worldwide, in both industrialized and developing countries, making IBD a global health problem that seriously affects quality of life. In 2019, there were approximately 4.
View Article and Find Full Text PDFCAR-T cell therapy in developing countries: how long should we wait?
J Immunother Cancer
December 2024
Center for Regenerative Medicine, Kathmandu, Nepal
Low- and middle-income countries (LMICs) face a significant burden of cancer prevalence and incidence. However, the survival rates for patients with cancer in these regions are notably lower than those in high-income countries, primarily due to late diagnosis and limited access to advanced treatments. Chimeric antigen receptor (CAR) T-cell therapy has demonstrated promising outcomes in certain terminally ill patients with cancer, yet access to this treatment remains limited in LMICs, including Nepal.
View Article and Find Full Text PDFSpatial-temporal characteristics and drivers of urban built-up areas land low-carbon efficiency in China.
Sci Rep
January 2025
School of Business Administration / Research Center for Energy Economics, Henan Polytechnic University, Jiaozuo, Henan, 454003, China.
Understanding the evolution of low-carbon efficiency in urban built-up areas is essential for developing countries striving to meet sustainable development goals. However, the mechanisms driving low-carbon efficiency and the associated development pathways remain underexplored. This study applies the Global Data Envelopment Analysis (DEA) model, the Global Malmquist-Luenberger Index, and econometric models to evaluate low-carbon efficiency and its determinants across China's urban built-up areas from 2010 to 2022.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!